WCM
PFE icon

Winebrenner Capital Management’s Pfizer PFE Stock Holding History

Winebrenner Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,512
Closed -$211K – 155
2026
Q1 		$211K Buy
+7,512
New +$200K 0.14% 129

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Winebrenner Capital Management's PFE Position: Q2 2026 in Review

Winebrenner Capital Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,512 shares — an estimated $211K sold.

Winebrenner Capital Management first reported a position in PFE in Q1 2026 and held it in 1 quarter. The position peaked at $211K in Q1 2026. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Winebrenner Capital Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Winebrenner Capital Management sold 7,512 Pfizer shares in Q2 2026, an estimated $211K.
  • Winebrenner Capital Management first reported a position in Pfizer in Q1 2026 and held it in 1 quarter.
  • Winebrenner Capital Management's Pfizer position peaked at $211K in Q1 2026.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Winebrenner Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.